Evidence map›Paper›PMID 39654660›Full record

ReviewExperimental biology and medicine (Maywood, N.J.)2024

Integrating artificial intelligence in strabismus management: current research landscape and future directions.

Dawen Wu, Xi Huang, Liang Chen, Peixian Hou, Longqian Liu, Guoyuan Yang

Abstract readReview
In one paragraph

Review in Experimental biology and medicine (Maywood, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Binocular Vision Anomalies: An Update on Prevalence, Impact, Technological and Treatment Developments and Current Challenges.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Artificial intelligence in ophthalmology: opportunities, challenges, and ethical considerations.Medical hypothesis, discovery & innovation ophthalmology journal · 2025
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dawen Wu *Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, China.
Xi Huang *Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, China.
Liang ChenDepartment of Ophthalmology, West China Hospital, Sichuan University, Chengdu, China.
Peixian HouDepartment of Ophthalmology, West China Hospital, Sichuan University, Chengdu, China.
Longqian LiuDepartment of Ophthalmology, West China Hospital, Sichuan University, Chengdu, China.
Guoyuan YangDepartment of Ophthalmology, West China Hospital, Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advancements in artificial intelligence (AI) are transforming strabismus management through improved screening, diagnosis, and surgical planning. Deep learning has notably enhanced diagnostic accuracy and optimized surgical outcomes. Despite these advancements, challenges such as the underrepresentation of diverse strabismus types and reliance on single-source data remain prevalent. Emphasizing the need for inclusive AI systems, future research should focus on expanding AI capabilities with large model technologies, integrating multimodal data to bridge existing gaps, and developing integrated management platforms to better accommodate diverse patient demographics and clinical scenarios.

Indexed as

Artificial IntelligenceStrabismusDeep LearningHumansartificial intelligencedeep learningeye carelarge modelmultimodalstrabismus

Identifiers

PMID39654660
PMCPMC11625544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.